Nanjing Hicin Pharmaceutical Co Ltd (300584) — Cash Flow Quality Index
Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Cash Flow Quality Index of -2.03x as of September 2025. Operating cash flow of CN¥-7.15 Million is below net income of CN¥3.52 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Nanjing Hicin Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nanjing Hicin Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Nanjing Hicin Pharmaceutical Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Nanjing Hicin Pharmaceutical Co Ltd (300584) cash conversion ratio.
Annual Cash Flow Quality Index for Nanjing Hicin Pharmaceutical Co Ltd (2013–2025)
Year-by-year earnings quality comparison for Nanjing Hicin Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.86x | CN¥78.09 Million | CN¥42.06 Million | ▲ +24.5% |
| 2024 | 1.49x | CN¥59.96 Million | CN¥40.22 Million | ▲ +126.2% |
| 2023 | 0.66x | CN¥23.93 Million | CN¥36.32 Million | ▲ +463.8% |
| 2022 | -0.18x | CN¥-5.82 Million | CN¥32.12 Million | ▼ -186.1% |
| 2021 | 0.21x | CN¥59.94 Million | CN¥284.83 Million | ▼ -84.4% |
| 2020 | 1.35x | CN¥73.39 Million | CN¥54.53 Million | ▲ +34.4% |
| 2019 | 1.00x | CN¥97.28 Million | CN¥97.16 Million | ▲ +7.9% |
| 2018 | 0.93x | CN¥77.21 Million | CN¥83.22 Million | ▲ +30.7% |
| 2017 | 0.71x | CN¥46.56 Million | CN¥65.60 Million | ▼ -14.9% |
| 2016 | 0.83x | CN¥37.74 Million | CN¥45.24 Million | ▼ -37.6% |
| 2015 | 1.34x | CN¥53.90 Million | CN¥40.33 Million | ▲ +88.2% |
| 2014 | 0.71x | CN¥24.29 Million | CN¥34.21 Million | ▼ -47.7% |
| 2013 | 1.36x | CN¥45.16 Million | CN¥33.29 Million | — |